Optimal conditionsfor propagation of rotavirus monovalent vaccine strain to use as a referencerotavirus for evaluation of potency valuesof monovalent rotavirus vaccine
Keywords:
Rotavirus vaccine, potencyAbstract
Rotavirus vaccine will be introduced to National Immunization Program in the future to reduce child mortality in Thailand caused a severe diarrhea in infants and children. Quality control of the vaccine to ensure the safety and effectiveness of rotavirus vaccine will be increased as well. Therefore, it is necessary to prepare rotavirus monovalent vaccine strain for using in quality control laboratory. This study was to determine optimal conditions for preparation of rotavirus monovalent vaccine strain infected cell culture in the presence of various concentrations of trypsin and to study harvesting virus in culture fluid in various conditions after freeze-thaw cycle 1 time, 2 times and 3 times, respectively comparing with harvesting viral vaccine directly from culture supernatant. Optimal conditions were used for the preparation of rotavirus monovalent vaccine strain that would be assigned with the potency values. The result showed that use of trypsin couldenhance rotavirus quantity in MA104 cells. Trypsin at 7.5 μg/ml trypsin/washing mediumboth in the titration medium and the maintenance medium and harvesting virus with 1F-T method were optimal conditions for preparation of rotavirus vaccine due to a highest potency values. When optimal conditions used for preparation of rotavirus monovalent vaccine strain, it was found that the geometric mean was 7.93 log10CCID50/1.5 ml with the range between 7.46-8.40 log10CCID50/1.5 ml. Each individual value from three analysts was not more than 0.5 log10CCID50/1.5 ml. It can be concluded that rotavirus monovalent vaccine strain prepared in the laboratory can be used as a reference rotavirus for quality control of monovalent rotavirus vaccine potency.
References
วิชัย สันติมาลีวรกุล และทศวรรณ จิตรวศินกุล. วัคซีนโรตาไวรัส : การพัฒนาและการนำมาใช้ทางคลินิก. ไทยไกษัชยนิพนธ์ 2550; 4(1): 1-12.
สำนักสารนิเทศ สำนักงานปลัดกระทรวง. หมอสุรวิทย์ เผย สธ. เตรียมบรรจุวัคซีน “ไวรัสโรตา” เข้าแผนสร้างเสริมภูมิคุ้มกันโรคแห่งชาติปี 2558 [cited 2014 Feb 4]; Available from: URL: http://www.moph.go.th/ops/iprg/include/admin_hotnew/show_hotnew.php?idHot_new=49880.
World Health Organization. Rotavirus vaccines WHO position paper - January 2013. Weekly Epidemiological Record (WER) 2013; 88(5): 49-64.
World Health Organization. Recommendations for the preparation, characterization and establishment of international and other biological reference standards. WHO Technical Report Series No. 932, 2006.
Twist EM, Kolonich K, Rubin DH. Propagation of rotaviruses in the presence of chicken serum. J Gen Virol 1984; 65(Pt 7): 1207-10.
Almeida JD, Hall T, Banatvala JE, Totterdell BM, Chrystie IL. The effect of trypsin on the growth of rotavirus. J Gen Virol 1978; 40(1): 213-8.
Clark SM, Roth JR, Clark ML, Barnett BB, Spendlove RS. Trypsin enhancement of rotavirus infectivity: mechanism of enhancement. J Virol 1981: 39(3): 816-22.
วันดี วราวิทย์ และอัจฉรีย์ อินทุโสมา. Rotavirus vaccine. กรุงเทพฯ: หน้า 28-33.
Martin J. Evaluating cell-line sensitivity. In: World Health Organization. Polio laboratory manual. 4th ed. Geneva, Switzerland: WHO; 2004. p. 73-80.
World Health Organization. Manual of laboratory methods for testing of vaccines used in the WHO Expanded Programme on Immunization (EPI). Geneva: WHO; 2001.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
